-
Something wrong with this record ?
Tuberculosis incidence in foreign-born people residing in European countries in 2020
A. Vasiliu, N. Köhler, E. Altpeter, TR. Ægisdóttir, M. Amerali, WA. de Oñate, Á. Bakos, S. D'Amato, DM. Cirillo, R. van Crevel, E. Davidaviciene, I. Demuth, J. Domínguez, R. Duarte, G. Günther, JP. Guthmann, S. Hatzianastasiou, LH. Holm, Z....
Language English Country Sweden
Document type Journal Article
NLK
Directory of Open Access Journals
from 1996
Free Medical Journals
from 1995
Freely Accessible Science Journals
from 1995-09-01
PubMed Central
from 2016
Europe PubMed Central
from 2016
Open Access Digital Library
from 1996-01-01
Open Access Digital Library
from 2016-01-01
Medline Complete (EBSCOhost)
from 2010-07-01
ROAD: Directory of Open Access Scholarly Resources
from 1995
- MeSH
- Incidence MeSH
- Humans MeSH
- Cross-Sectional Studies MeSH
- Tuberculosis * diagnosis epidemiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
- Somalia MeSH
BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most from targeted TB prevention screening.MethodsThe Tuberculosis Network European Trials group collected, by cross-sectional survey, numbers of foreign-born TB patients residing in European Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) in 2020 from the 10 highest ranked countries of origin in terms of TB cases in each country of residence. Tuberculosis incidence rates (IRs) in countries of residence were compared with countries of origin.ResultsData on 9,116 foreign-born TB patients in 30 countries of residence were collected. Main countries of origin were Eritrea, India, Pakistan, Morocco, Romania and Somalia. Tuberculosis IRs were highest in patients of Eritrean and Somali origin in Greece and Malta (both > 1,000/100,000) and lowest among Ukrainian patients in Poland (3.6/100,000). They were mainly lower in countries of residence than countries of origin. However, IRs among Eritreans and Somalis in Greece and Malta were five times higher than in Eritrea and Somalia. Similarly, IRs among Eritreans in Germany, the Netherlands and the UK were four times higher than in Eritrea.ConclusionsCountry of origin TB IR is an insufficient indicator when targeting foreign-born populations for active case finding or TB prevention policies in the countries covered here. Elimination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks.
1st Faculty of Medicine and Faculty Thomayer Hospital Prague Czechia
Belgian Lung and Tuberculosis Association Brussels Belgium
Catholic University Ruzomberok Ruzomberok Slovakia
Centre for Health Security and Communicable Disease Control Directorate of Health Iceland
Centro Hospitalar de Vila Nova de Gaia Espinho Porto Portugal
Centro Nacional de Epidemiología Instituto de Salud Carlos 3 Madrid Spain
CIBER Enfermedades Respiratorias
Department of Chemistry Department of Clinical Microbiology Umeå University Sweden
Department of Clinical Microbiology Umeå University Sweden
Department of Infectious Diseases Oslo University Hospital Ullevaal Norway
Department of Infectious Diseases Rigshospitalet University Hospital Copenhagen Denmark
Department of Medical Sciences School of Medicine University of Namibia Windhoek Namibia
Division of Clinical Infectious Diseases Research Center Borstel Borstel Germany
Division of Infectious Diseases Santé publique France Saint Maurice France
Division of Pneumology Onze Lieve Vrouw Ziekenhuis Aalst Aalst Belgium
Emerging Bacterial Pathogens Unit IRCCS San Raffaele Scientific Institute Milan Italy
Finnish Lung Health Association Helsinki Finland
Flemish Association of Respiratory Health and TB Control Leuven Belgium
German Center for Infection Research TTU TB Borstel Germany
Global Public Health Unit Wolfson Institute of Population Health Barts
Health Directorate of Luxembourg Luxembourg
Health Service Executive Health Protection Surveillance Centre Dublin Ireland
ICBAS Instituto de Ciências Biomédicas Abel Salazar Universidade do Porto
INNOVA4TB consortium Badalona Barcelona Spain
Institut d'Investigació Germans Trias i Pujol
ISPUP Instituto de Saúde Pública da Universidade do Porto Porto Portugal
Koranyi National Institute for Pulmonology Budapest Hungary
Marius Nasta Institute of Pulmonology Bucharest Romania
National Institute for TB Lung Diseases and Thoracic Surgery Vysne Hagy Slovakia
National TB Surveillance Unit University Hospital Bulovka Prague Czechia
Respiratory Medicine and International Health University of Lübeck Lübeck Germany
Riga East University Hospital TB and Lung Disease Clinic Riga Latvia
Swiss Federal Office of Public Health Division of Communicable Diseases Bern Switzerland
The London School of Medicine and Dentistry Queen Mary University of London London United Kingdom
The National University Hospital of Iceland Pharmaceutical Services Reykjavik Iceland
Tuberculosis Register of the Republic of Slovenia University Clinic Golnik Golnik Slovenia
Universitat Autònoma de Barcelona
University Hospital Centre Zagreb Department for Lung diseases Zagreb Croatia
University of Zagreb School of Medicine Zagreb Croatia
Wallenberg Centre for Molecular Medicine Umeå University Sweden
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001114
- 003
- CZ-PrNML
- 005
- 20240213093626.0
- 007
- ta
- 008
- 240109s2023 sw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2807/1560-7917.ES.2023.28.42.2300051 $2 doi
- 035 __
- $a (PubMed)37855907
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Vasiliu, Anca $u Baylor College of Medicine, Department of Pediatrics, Global and Immigrant Health, Global Tuberculosis Program, Houston, Texas, United States
- 245 10
- $a Tuberculosis incidence in foreign-born people residing in European countries in 2020 / $c A. Vasiliu, N. Köhler, E. Altpeter, TR. Ægisdóttir, M. Amerali, WA. de Oñate, Á. Bakos, S. D'Amato, DM. Cirillo, R. van Crevel, E. Davidaviciene, I. Demuth, J. Domínguez, R. Duarte, G. Günther, JP. Guthmann, S. Hatzianastasiou, LH. Holm, Z. Herrador, U. Hribar, C. Huberty, E. Ibraim, S. Jackson, M. Jensenius, KS. Josefsdottir, A. Koch, M. Korzeniewska-Kosela, L. Kuksa, H. Kunst, C. Lienhardt, B. Mahler, MJ. Makek, I. Muylle, J. Normark, A. Pace-Asciak, G. Petrović, D. Pieridou, G. Russo, O. Rzhepishevska, HJF. Salzer, MS. Marques, D. Schmid, I. Solovic, M. Sukholytka, P. Svetina, M. Tyufekchieva, T. Vasankari, P. Viiklepp, K. Villand, J. Wallenfels, S. Wesolowski, AM. Mandalakas, L. Martinez, D. Zenner, C. Lange, TBnet
- 520 9_
- $a BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most from targeted TB prevention screening.MethodsThe Tuberculosis Network European Trials group collected, by cross-sectional survey, numbers of foreign-born TB patients residing in European Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) in 2020 from the 10 highest ranked countries of origin in terms of TB cases in each country of residence. Tuberculosis incidence rates (IRs) in countries of residence were compared with countries of origin.ResultsData on 9,116 foreign-born TB patients in 30 countries of residence were collected. Main countries of origin were Eritrea, India, Pakistan, Morocco, Romania and Somalia. Tuberculosis IRs were highest in patients of Eritrean and Somali origin in Greece and Malta (both > 1,000/100,000) and lowest among Ukrainian patients in Poland (3.6/100,000). They were mainly lower in countries of residence than countries of origin. However, IRs among Eritreans and Somalis in Greece and Malta were five times higher than in Eritrea and Somalia. Similarly, IRs among Eritreans in Germany, the Netherlands and the UK were four times higher than in Eritrea.ConclusionsCountry of origin TB IR is an insufficient indicator when targeting foreign-born populations for active case finding or TB prevention policies in the countries covered here. Elimination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a průřezové studie $7 D003430
- 650 12
- $a tuberkulóza $x diagnóza $x epidemiologie $7 D014376
- 651 _2
- $a Somálsko $7 D012998
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Köhler, Niklas $u Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany $u German Center for Infection Research (DZIF), TTU-TB, Borstel, Germany $u Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany
- 700 1_
- $a Altpeter, Ekkehardt $u Swiss Federal Office of Public Health, Division of Communicable Diseases, Bern, Switzerland
- 700 1_
- $a Ægisdóttir, Tinna Rán $u The National University Hospital of Iceland, Pharmaceutical Services, Reykjavik, Iceland
- 700 1_
- $a Amerali, Marina $u Tuberculosis Control Office, Department of Respiratory Infections, Directorate for Epidemiological Surveillance & Intervention, National Public Health Organization (NPHO), Athens, Greece
- 700 1_
- $a de Oñate, Wouter Arrazola $u Belgian Lung and Tuberculosis Association, Brussels, Belgium $u Flemish Association of Respiratory Health and TB Control, Leuven, Belgium
- 700 1_
- $a Bakos, Ágnes $u Koranyi National Institute for Pulmonology, Budapest, Hungary
- 700 1_
- $a D'Amato, Stefania $u Prevention of Communicable Diseases and International Prophylaxis, General Direction of Health Prevention, Ministry of Health of Italy, Rome, Italy
- 700 1_
- $a Cirillo, Daniela Maria $u Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a van Crevel, Reinout $u Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands $u Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- 700 1_
- $a Davidaviciene, Edita $u Vilnius University hospital Santaros Klinikos, Department of Tuberculosis State information system, Vilnius, Lithuania
- 700 1_
- $a Demuth, Irène $u Health Directorate of Luxembourg, Luxembourg
- 700 1_
- $a Domínguez, Jose $u Institut d'Investigació Germans Trias i Pujol; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias; INNOVA4TB consortium Badalona, Barcelona, Spain
- 700 1_
- $a Duarte, Raquel $u ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto $u ISPUP - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal $u Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto, Portugal
- 700 1_
- $a Günther, Gunar $u Department of Pulmonary Medicine and Allergology, Inselspital, Bern University Hospital, University of Bern, Switzerland $u Department of Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia
- 700 1_
- $a Guthmann, Jean-Paul $u Division of Infectious Diseases, Santé publique France, Saint-Maurice, France
- 700 1_
- $a Hatzianastasiou, Sophia $u Tuberculosis Control Office, Department of Respiratory Infections, Directorate for Epidemiological Surveillance & Intervention, National Public Health Organization (NPHO), Athens, Greece
- 700 1_
- $a Holm, Louise Hedevang $u Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
- 700 1_
- $a Herrador, Zaida $u Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Hribar, Urška $u Tuberculosis Register of the Republic of Slovenia, University Clinic Golnik, Golnik, Slovenia
- 700 1_
- $a Huberty, Conny $u Health Directorate of Luxembourg, Luxembourg
- 700 1_
- $a Ibraim, Elmira $u Marius Nasta Institute of Pulmonology, Bucharest, Romania
- 700 1_
- $a Jackson, Sarah $u Infectious Diseases; Health Service Executive Health Protection Surveillance Centre, Dublin, Ireland
- 700 1_
- $a Jensenius, Mogens $u Department of Infectious Diseases, Oslo University Hospital, Ullevaal, Norway
- 700 1_
- $a Josefsdottir, Kamilla Sigridur $u Centre for Health Security and Communicable Disease Control, Directorate of Health, Iceland
- 700 1_
- $a Koch, Anders $u Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark $u Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark
- 700 1_
- $a Korzeniewska-Kosela, Maria $u Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
- 700 1_
- $a Kuksa, Liga $u Riga East University Hospital, TB and Lung Disease Clinic, Riga, Latvia
- 700 1_
- $a Kunst, Heinke $u Blizard Institute, The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
- 700 1_
- $a Lienhardt, Christian $u Unité Unité Mixte Internationale 233 IRD - U1175 INSERM - Université de Montpellier, Institut de Recherche pour le Développement (IRD), Montpellier, France $u Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
- 700 1_
- $a Mahler, Beatrice $u Marius Nasta Institute of Pulmonology, Bucharest, Romania $u Department Cardio-thoracic, Pneumophtisiology II, University of Medicine and Pharmacy "Carol Davila" Bucharest, Romania
- 700 1_
- $a Makek, Mateja Janković $u University of Zagreb, School of Medicine Zagreb, Croatia $u University Hospital Centre Zagreb, Department for Lung diseases, Zagreb, Croatia
- 700 1_
- $a Muylle, Inge $u Division of Pneumology, Onze-Lieve-Vrouw Ziekenhuis (OLV) Aalst, Aalst, Belgium
- 700 1_
- $a Normark, Johan $u Department of Clinical Microbiology, Umeå University, Sweden $u Wallenberg Centre for Molecular Medicine, Umeå University, Sweden
- 700 1_
- $a Pace-Asciak, Analita $u Infectious Disease Prevention and Control Unit, Health Promotion and Disease Prevention Directorate, Superintendence of Public Health, Ministry for Health of Malta, La Valetta, Malta
- 700 1_
- $a Petrović, Goranka $u Respiratory Diseases and Travel Medicine Department with Vaccination Unit, Infectious Diseases Epidemiology ServiceDepartment, Croatian Institute of Public Health, Zagreb, Croatia
- 700 1_
- $a Pieridou, Despo $u Cyprus National Reference Laboratory for Mycobacteria, Microbiology Department, Nicosia General Hospital, Nicosia, Cyprus
- 700 1_
- $a Russo, Giulia $u Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Rzhepishevska, Olena $u Department of Chemistry, Department of Clinical Microbiology, Umeå University, Sweden
- 700 1_
- $a Salzer, Helmut J F $u Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4- Pneumology, Kepler University Hospital, Linz, Austria $u Faculty of Medicine, Johannes-Kepler-University, Linz, Austria and Ignaz Semmelweis Institut, Interuniversity Institute for Infection Resarch, Vienna, Austria
- 700 1_
- $a Marques, Marta Sá $u Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto, Portugal
- 700 1_
- $a Schmid, Daniela $u Unit for Infectious Diseases Diagnostics and Infectious Diseases Epidemiology, Centre for Pathophysiology, Infectious Diseases and Immunology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Solovic, Ivan $u National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Slovakia $u Catholic University Ruzomberok, Ruzomberok, Slovakia
- 700 1_
- $a Sukholytka, Mariya $u First Faculty of Medicine and Faculty Thomayer Hospital Prague, Czechia
- 700 1_
- $a Svetina, Petra $u National TB Program and Tuberculosis Registry of Republic of Slovenia, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
- 700 1_
- $a Tyufekchieva, Mariya $u Health Promotion and Prevention Unit, Directorate Public Health Protection and Health Control, Ministry of Health of Bulgaria, Sofia, Bulgaria
- 700 1_
- $a Vasankari, Tuula $u University of Turku, Division of Medicine, Department of Pulmonary Diseases and Clinical Allergology, Turku, Finland $u Finnish Lung Health Association (Filha ry), Helsinki, Finland
- 700 1_
- $a Viiklepp, Piret $u Estonian Tuberculosis Register, Dept. of Registries, National Institute for Health Development, Tallinn, Estonia
- 700 1_
- $a Villand, Kersti $u Estonian Tuberculosis Register, Dept. of Registries, National Institute for Health Development, Tallinn, Estonia
- 700 1_
- $a Wallenfels, Jiri $u National TB Surveillance Unit, University Hospital Bulovka, Prague, Czechia
- 700 1_
- $a Wesolowski, Stefan $u Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
- 700 1_
- $a Mandalakas, Anna-Maria $u Baylor College of Medicine, Department of Pediatrics, Global and Immigrant Health, Global Tuberculosis Program, Houston, Texas, United States $u Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany
- 700 1_
- $a Martinez, Leonardo $u Boston University, School of Public Health, Department of Epidemiology, Boston, Massachusetts, United States
- 700 1_
- $a Zenner, Dominik $u Global Public Health Unit, Wolfson Institute of Population Health Barts $u The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
- 700 1_
- $a Lange, Christoph $u Baylor College of Medicine, Department of Pediatrics, Global and Immigrant Health, Global Tuberculosis Program, Houston, Texas, United States $u Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany $u German Center for Infection Research (DZIF), TTU-TB, Borstel, Germany $u Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany
- 710 2_
- $a TBnet
- 773 0_
- $w MED00174364 $t Euro surveillance $x 1560-7917 $g Roč. 28, č. 42 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37855907 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093623 $b ABA008
- 999 __
- $a ok $b bmc $g 2049614 $s 1210808
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 28 $c 42 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
- LZP __
- $a Pubmed-20240109
